SkinHealth Sets Sept 22 Vote on 1-for-5 to 1-for-20 Reverse Split to Avoid Nasdaq Delisting

summarizeSummary

SkinHealth Systems will hold a special meeting on September 22, 2026 to vote on a reverse stock split of 1-for-5 to 1-for-20, aimed at regaining Nasdaq's $1.00 minimum bid price and avoiding a potential $353.2 million note repurchase obligation.

check_boxKey Events · Corporate Governance and Compliance · SKIN

• Reverse Split Vote Set

  Special meeting on September 22, 2026 to approve a reverse stock split at a ratio between 1-for-5 and 1-for-20, with the board having discretion to set the exact ratio.

• Nasdaq Compliance Pressure

  Stock closed at $0.6610 on August 7, 2026, below the $1.00 minimum bid requirement. Initial compliance deadline is November 4, 2026.

• Note Repurchase Risk

  If delisted, a Fundamental Change would allow holders of $103.2M 2026 Notes and $250.0M 2028 Notes to demand repurchase, totaling $353.2M versus $206.1M cash as of June 30, 2026.

• Board Discretion

  Board may abandon the reverse split at any time before effectiveness, even after shareholder approval.

auto_awesomeAnalysis · SKIN · Industrial Applications And Services

The definitive proxy sets the shareholder vote for September 22, 2026 on a reverse stock split ranging from 1-for-5 to 1-for-20. The board has discretion to choose the exact ratio and to abandon the split. The primary driver is Nasdaq compliance: the stock closed at $0.6610 on August 7, 2026, below the $1.00 minimum bid requirement, with an initial compliance deadline of November 4, 2026. Failure to regain compliance could trigger a Fundamental Change under the company's convertible notes, forcing a potential repurchase of up to $353.2 million in principal, which exceeds the $206.1 million cash balance as of June 30, 2026. The reverse split is a critical step to avoid delisting and a liquidity crisis.